Irinotecan: all 829 studies that test it
Page 7 of 9. Open to participants first (121), then studies with results posted, then the rest; newest registration first within each.
- Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney CancerCompletedNCT00401128Phase 2
- Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal CancerStatus unknownNCT00392470Phase 1
- Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to FluorouracilCompletedNCT00389870Phase 3
- Irinotecan and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases From Solid TumorsCompletedNCT00389584Phase 1/2
- Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid TumorsCompletedNCT00364143Phase 1
- SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerTerminatedNCT00361244Phase 1/2
- Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal TractCompletedNCT00353015Phase 2
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant GliomaCompletedNCT00352521Phase 2
- A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung CancerCompletedNCT00349492Phase 3
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
- S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric CancerStatus unknownNCT00343668Phase 2
- FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal CancerTerminatedNCT00323011Phase 2
- Irinotecan Discontinuation and Reintroduction for Advanced Colorectal CancerTerminatedNCT00320320Phase 2
- ILF With/Without Cisplatin for Advanced Gastric CancerStatus unknownNCT00320294Phase 2
- Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCStatus unknownNCT00319800Phase 2
- Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal CancerCompletedNCT00318903Phase 2
- IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal CancerSuspendedNCT00316745Phase 3
- Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerTerminatedNCT00316433Phase 2
- Sequential Versus Combination Chemotherapy in Advanced Colorectal CarcinomaCompletedNCT00312000Phase 3
- Liposomal SN-38 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00311610Phase 2
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast CancerCompletedNCT00303992Phase 2
- Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00303771Phase 3
- Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00303745Phase 2
- Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal CancerTerminatedNCT00296062Phase 1
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By SurgeryTerminatedNCT00290719Phase 1
- Irinotecan in Treating Young Patients With Refractory or Recurrent HepatoblastomaStatus unknownNCT00287976Phase 2
- Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal CancerCompletedNCT00284258Phase 2/3
- High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant GliomaCompletedNCT00283556Phase 1/2
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- Irinotecan in Treating Patients With Newly Diagnosed Ewing's SarcomaCompletedNCT00276692Phase 2
- Irinotecan and Cetuximab in Treating Patients With Metastatic Breast CancerCompletedNCT00275041Phase 2
- Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable MetastasesCompletedNCT00268398Phase 3
- Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory GliomasCompletedNCT00268359Phase 2
- Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNCT00264134Phase 1/2
- Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00258232Phase 2
- Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction CarcinomaTerminatedNCT00256269Phase 2
- Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.CompletedNCT00254137Phase 2
- CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of CamptoCompletedNCT00251888Phase 1
- A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS TumorsCompletedNCT00251797Phase 1
- Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor MalignanciesCompletedNCT00251407Phase 1
- Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00248482Phase 2
- Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerWithdrawnNCT00233623Phase 2
- Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
- Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent MalignancyCompletedNCT00222443Phase 1
- Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the PancreasCompletedNCT00220649Phase 1
- Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI TumoursCompletedNCT00220168Phase 4
- A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI TumoursCompletedNCT00220064Phase 2
- Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00217711Phase 1/2
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II TrialCompletedNCT00213486Phase 2
- Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerSuspendedNCT00209664Phase 2
- Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal CancerStatus unknownNCT00209651Phase 2
- Phase I/II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric CancerCompletedNCT00209638Phase 1/2
- Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal CancerCompletedNCT00209625Phase 1/2
- Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerCompletedNCT00201747Phase 2
- Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic CancerCompletedNCT00192712Phase 2/3
- Clinical and Pharmacokinetic Trial of Intra-Abdominal IrinotecanCompletedNCT00183859Phase 1
- Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal CancersCompletedNCT00183846Phase 1
- A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal CancerTerminatedNCT00183807Phase 2
- Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00182806Phase 2
- Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal ChemohyperthermiaTerminatedNCT00180960Phase 2
- Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic CancerTerminatedNCT00177853Phase 1
- Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal CarcinomaCompletedNCT00176774Phase 2
- Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal CancerCompletedNCT00165490Phase 2
- Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric CancerCompletedNCT00165464Phase 2
- Irinotecan Versus Only Best Supportive Care for Gastric CancerCompletedNCT00144378Phase 3
- Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid TumorsCompletedNCT00143533Phase 1
- Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung CancerCompletedNCT00139711Phase 2
- Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00138216Phase 1
- Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsCompletedNCT00138060Phase 4
- Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerCompletedNCT00137852Phase 2
- S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach CancerStatus unknownNCT00134095Phase 2
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00134069Phase 1
- ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1
- Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerCompletedNCT00132054Phase 1
- 17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00119236Phase 1
- Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerCompletedNCT00118235Phase 2
- Irinotecan and Selenium in Treating Patients With Advanced Solid TumorsCompletedNCT00112892Phase 1
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112658Phase 2/3
- Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal CancerTerminatedNCT00106262Phase 2
- Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung CancerCompletedNCT00104793Phase 2
- Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNCT00104754Phase 2
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00099125Phase 2
- N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerStatus unknownNCT00091312Phase 3
- Irinotecan and Flavopiridol in Treating Patients With Advanced Liver CancerCompletedNCT00087282Phase 2
- Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00084877Phase 1
- Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
- Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT00084604Phase 2
- Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerCompletedNCT00083148Phase 1
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00080951Phase 2
- Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00079352Phase 1
- Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerCompletedNCT00079118Phase 2
- Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk RhabdomyosarcomaActive, not recruitingNCT00077285Phase 2
- FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or RectumTerminatedNCT00077233Phase 3
- Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal CancerStatus unknownNCT00075738Phase 2
- Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal CancerStatus unknownNCT00075595Phase 2